MedTrace Logo

Angelman Natural History Study - FAST Spain

NCT06115109 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-04-03

No results posted yet for this study

Summary

The goal of this study is to conduct a prospective, longitudinal study to observe the natural clinical progression and disease outcome of AS patients receiving no disease-modified intervention, with the purpose of obtaining data that will be useful for future clinical trials.

Conditions

Interventions

OTHER

Non intervention, Observational study

Non intervention, Observational study

Sponsors & Collaborators

  • Parc Taulí Hospital Universitari

    collaborator OTHER

  • Puerta de Hierro University Hospital

    lead OTHER

Principal Investigators

  • BELEN RUIZ ANTORAN, MD, Ph · Clinical Pharmacology Deparment, Hospital Universitario Puerta de Hierro Majadahonda

Eligibility

Min Age
3 Months
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-01
Primary Completion
2024-12-31
Completion
2025-07-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06115109 on ClinicalTrials.gov